Shape Therapeutics
shapetx.comLocations
United States · Seattle, WA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series B
founded in
2018
Shape Therapeutics’ next-generation gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. This is done by redirecting the human cellular machinery already present in our cells, thereby bypassing risks of in vivo immunogenicity and permanent off-target damages commonly associated with CRISPR-based technologies.
Something looks off?Open jobs at Shape Therapeutics